diagnostics

Microbiome Testing: What It Can (and Can't) Tell You About Your Longevity

Your gut microbiome influences immunity, metabolism, inflammation, and even cognition. Microbiome testing has arrived at consumer level — but what does it actually tell you, and what should you do with the data?

Dr. Sarah Chen8 min read
Written by our Chief Medical Reviewer
Every claim cross-checked against peer-reviewed literature. Our process
microbiomegut healthdiagnosticslongevityViomeZoegut bacteriadiversity
Microbiome Testing: What It Can (and Can't) Tell You About Your Longevity

Quick Verdict

77/100

Microbiome testing provides genuinely useful data about gut composition and diversity — key longevity markers. The actionable insights are currently limited: we know more about which bacteria are good or bad than how to reliably change specific populations. Viome and Zoe offer the most clinically meaningful consumer tests. Best used as a baseline and motivation for dietary change, not a precision medicine tool yet.

Top Picks

We may earn a commission if you buy through our links — at no extra cost to you. Commissions never influence rankings or scores. How we stay independent

Best Consumer Test

Viome Gut Intelligence Test

Viome · $179.00

84

Pros

  • Metatranscriptomic sequencing (measures active gene expression, not just DNA presence)
  • Personalized food recommendations based on your results
  • Includes inflammation and gut health scores
  • Has published peer-reviewed validation data

Cons

  • Proprietary scoring — limited scientific transparency
  • Food recommendations sometimes overly restrictive
  • Results can vary between test kits
Best Science-Backed

Zoe Gut Microbiome Test

Zoe · $299.00

82

Pros

  • Developed from PREDICT study (largest nutrition research program globally)
  • Combines microbiome + blood fat + glucose response testing
  • Randomised trial published showing ZOE users improve diet quality
  • Personalised nutrition recommendations with scientific backing

Cons

  • Higher cost
  • Programme requires ongoing engagement to get full value
  • UK/US only currently

Why the Microbiome Matters for Longevity

The human gut contains approximately 38 trillion microorganisms — comparable in number to human cells — comprising 1,000+ species of bacteria, archaea, fungi, and viruses. This ecosystem, the gut microbiome, is not a passive passenger. It is an active metabolic and immune organ.

The microbiome:

  • Produces short-chain fatty acids (SCFAs — particularly butyrate) that fuel colon cells, regulate inflammation, and improve insulin sensitivity
  • Synthesises vitamins (B12, K2, folate, biotin)
  • Regulates immune system development and function — 70% of immune tissue is gut-associated
  • Produces neurotransmitters (90% of serotonin is produced in the gut)
  • Influences systemic inflammation through bacterial metabolite production and intestinal barrier integrity
  • Modulates the hypothalamic-pituitary-adrenal (HPA) axis — the gut-brain axis affects stress response and mood

The longevity connection: Centenarian studies consistently find that extremely long-lived people have distinct microbiome profiles — higher diversity, elevated Akkermansia muciniphila and Faecalibacterium prausnitzii, lower pro-inflammatory species. Whether this is a cause or consequence of healthy ageing remains debated, but the association is robust.


What Microbiome Testing Measures

Diversity

The most consistently validated longevity marker in microbiome research. Higher alpha diversity (number of different species present) correlates with better metabolic health, lower inflammation, reduced disease risk, and longevity in observational studies.

Modern Western diets, antibiotics, and sedentary lifestyles all reduce diversity. Traditional populations and blue zone inhabitants show significantly higher diversity than typical Western populations.

Testing value: A low diversity score is a meaningful signal and one that responds to dietary intervention.

Keystone Species

Certain bacteria are disproportionately important:

Akkermansia muciniphila: Lives in the gut mucus layer; associated with gut barrier integrity, metabolic health, and reduced cardiovascular risk. Low Akkermansia is associated with obesity, type 2 diabetes, and IBD. Elevated by pomegranate extract, Concord grape, cranberry, and metformin.

Faecalibacterium prausnitzii: One of the most abundant species in healthy guts; major butyrate producer; strongly anti-inflammatory. Depleted in IBD, depression, and metabolic disease. Elevated by fibre diversity.

Bifidobacterium: Declines with age; associated with immune function, lactose tolerance, and gut barrier integrity. Elevated by fermented dairy, inulin-type fructans.

Lactobacillus: Produces lactate and some SCFAs; associated with immune modulation; foundational probiotic species.

Functional Outputs

More sophisticated tests (Viome) measure what the bacteria are doing — gene expression of active metabolic pathways — rather than just which species are present. This is more clinically meaningful: the same species can produce different metabolites depending on what it is being fed and which genes it is expressing.

Butyrate Production Potential

Butyrate is the primary fuel for colonocytes (colon cells) and has systemic anti-inflammatory effects via histone deacetylase inhibition. Low butyrate production is associated with leaky gut, colon cancer risk, and systemic inflammation. Elevated by a diet high in resistant starch and diverse fibre.


Consumer Testing Options

Viome ($179–299)

Technology: Metatranscriptomic sequencing — measures RNA (active gene expression) rather than DNA. This is more expensive and technically demanding than standard 16S sequencing used by most consumer tests, but more informative about what bacteria are actually doing.

What you get: Gut microbiome composition, functional pathway analysis, personalised food recommendations (superfoods, beneficials, minimise, avoid), and scores for gut health, inflammation, metabolic fitness, and immune system fitness.

Published validation: Viome has published peer-reviewed data. Independent analysis of their recommendations has been mixed — the personalised food categories are sometimes inconsistent and the proprietary algorithm limits external validation.

Best for: People who want detailed personalised food recommendations based on their microbiome.

Zoe ($299)

Technology: 16S rRNA sequencing for microbiome; also includes a blood fat test (triglyceride response to meals) and continuous glucose monitoring (10 days). This multi-omic approach connects microbiome data to actual metabolic responses.

What makes Zoe different: Developed from the PREDICT study — the largest nutritional science research programme in history (20,000+ participants across UK and US). The microbiome scoring is built on genuine population-level data linking microbiome composition to metabolic outcomes.

Published RCT: A 2022 trial (Nature Medicine) found that ZOE personalised dietary recommendations significantly improved diet quality and gut microbiome composition vs standard healthy eating advice.

Best for: People who want the most scientifically grounded consumer microbiome testing, particularly those interested in metabolic responses to food.

Thryve / Ombre ($79–149)

Budget option using 16S sequencing. Provides species-level data and probiotic recommendations. Less sophisticated than Viome or Zoe but adequate for basic diversity and keystone species assessment.

Best for: Cost-conscious users wanting basic microbiome data.

Clinical Options (Physician-Ordered)

Doctor's Data and Genova Diagnostics offer clinical stool testing that combines microbiome sequencing with functional markers (calprotectin, secretory IgA, zonulin, digestive enzymes, parasites, pathogenic bacteria). More expensive ($300–500) but provides a more complete clinical picture when gut symptoms are present.


The Current Limitations

The microbiome testing field is advancing rapidly, but honest assessment requires acknowledging what we do not yet know:

1. Causation vs correlation: We know that certain microbiome patterns correlate with health outcomes. We do not yet know whether changing the microbiome changes the outcomes, or whether healthy behaviour produces both the microbiome pattern and the health outcome independently.

2. Individual variability: The same diet produces different microbiome responses in different people — one reason precise dietary recommendations based on microbiome data are difficult.

3. Test reproducibility: Microbiome composition varies day to day based on what you ate, hydration, stress, and transit time. A single test captures a snapshot; multiple tests across different days would be more representative.

4. Reference ranges: Unlike blood biomarkers, there are no universally agreed "normal" ranges for microbiome species abundances. Consumer companies define their own scoring systems.

5. Probiotic specificity: Most people's first instinct after microbiome testing is to take probiotics. The evidence for probiotics durably changing gut composition is weak — most supplemented bacteria do not colonise; they transit through. Dietary change (more fibre diversity) is consistently more effective at shifting microbiome composition.


What Actually Moves the Microbiome

If your test reveals low diversity, dysbiosis, or low keystone species, these interventions have the most evidence:

Increase fibre diversity (most important):

  • Aim for 30+ different plant foods per week (Tim Spector's research recommendation)
  • Each fibre type feeds different bacterial species — diversity of fibre creates diversity of bacteria
  • Include resistant starch (cold cooked potatoes, green bananas, legumes), inulin (garlic, onion, leeks, asparagus), pectin (apples, citrus), and beta-glucan (oats)

Fermented foods (well-evidenced):

  • The 2021 Sonnenburg/Gardner Stanford trial (Cell) showed 10 weeks of high-fermented food diet (kimchi, kefir, kombucha, yogurt, sauerkraut) increased microbiome diversity and reduced 19 inflammatory markers — a striking result
  • More effective for diversity than high-fibre diet alone
  • Include: kefir, live yogurt, kimchi, sauerkraut, miso, tempeh, kombucha

Polyphenols:

  • Feed Akkermansia and Bifidobacterium preferentially
  • High sources: berries, pomegranate, dark chocolate, green tea, red wine (in moderation), extra virgin olive oil

Exercise:

  • Regular aerobic exercise independently increases microbiome diversity — particularly butyrate-producing species
  • Effects are maintained only with ongoing exercise

Reduce antibiotics when possible:

  • A single course of broad-spectrum antibiotics can reduce diversity by 30–50% with incomplete recovery over months
  • When antibiotics are necessary, follow with 4+ weeks of high-fibre and fermented food intake to support recovery

Akkermansia muciniphila specifically:

  • Elevated by pomegranate extract (500mg/day), Concord grape polyphenols, cranberry extract
  • Metformin significantly increases Akkermansia (a proposed mechanism for metformin's metabolic benefits)
  • Pasteurised Akkermansia probiotic (Pendulum) — one of the few probiotics with evidence for actual colonisation

When to Test

Baseline: Once, to understand your starting composition and diversity score.

After dietary intervention: Retest 3–6 months after a sustained dietary change (adding 30 plant foods/week, daily fermented foods) to assess whether composition shifted.

After antibiotics: Test 2–3 months after a course of antibiotics to assess recovery.

Annual: Not necessary for most people; the data changes slowly with sustained lifestyle patterns.


Bottom Line

Microbiome testing is at an interesting inflection point — the science is compelling, the technology has arrived at consumer pricing, but the actionable precision is still maturing. A Viome or Zoe test gives you real information about your gut health and concrete (if imperfect) dietary targets.

The most important thing a microbiome test can do is motivate genuine dietary change — specifically, adding 30+ plant food varieties per week and incorporating daily fermented foods. If a $179 test is what it takes to make that change permanent, it has paid for itself many times over in terms of the downstream health effects.

About the Author

SC

Dr. Sarah Chen

Chief Medical Reviewer

MD with 12 years in preventive medicine and longevity research. Former researcher at UCSF. Specialises in metabolic health, diagnostics, and evidence-based supplementation.

MD, Internal Medicine. Board-certified. Former UCSF researcher.Meet the team

Continue Reading

Related Articles